Does t-PA have a role in the treatment of crescentic glomerulonephritis?
McCluskey
R T
RT
Massachusetts General Hospital, Boston.
Andres
G A
GA
D000818:Animals; D004195:Disease Models, Animal; D005337:Fibrin / Q000378:metabolism; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D007678:Kidney Glomerulus / Q000378:metabolism / Q000473:pathology; D010959:Tissue Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use*
D005337:Fibrin; D010959:Tissue Plasminogen Activator